Pulmonary hypertension
RecruitingTesting the safety of stopping riociguat in patients with chronic thromboembolic pulmonary hypertension after successful balloon pulmonary angioplasty treatment
Testing the safety of stopping riociguat in patients with chronic thromboembolic pulmonary hypertension after successful balloon pulmonary angioplasty treatment
- Disease:Pulmonary hypertension
- Substances:Riociguat
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Riociguat
- Sponsor:Amsterdam UMC Stichting








